{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:56:04Z","timestamp":1773309364855,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Complement activation plays important roles in the pathogenesis of central nervous system (CNS) diseases. Patients face neurological disorders due to the development of complement activation, which contributes to cell apoptosis, brain edema, blood-brain barrier dysfunction and inflammatory infiltration. We previously reported that induced neural stem cells (iNSCs) can promote neurological functional recovery in closed head injury (CHI) animals. Remarkably, we discovered that local iNSC grafts have the potential to modulate CNS inflammation post-CHI. In this study, we aimed to explore the role of systemically delivered iNSCs in complement activation following CNS injury. Our data showed that iNSC grafts decreased the levels of sera C3a and C5a and down-regulated the expression of C3d, C9, active Caspase-3 and Bax in the brain, kidney and lung tissues of CHI mice. Furthermore, iNSC grafts decreased the levels of C3d<jats:sup>+<\/jats:sup>\/NeuN<jats:sup>+<\/jats:sup>, C5b-9<jats:sup>+<\/jats:sup>\/NeuN<jats:sup>+<\/jats:sup>, C3d<jats:sup>+<\/jats:sup>\/Map2<jats:sup>+<\/jats:sup> and C5b-9<jats:sup>+<\/jats:sup>\/Map2<jats:sup>+<\/jats:sup> neurons in the injured cortices of CHI mice. Subsequently, we explored the mechanisms underlying these effects. With flow cytometry analysis, we observed a dramatic increase in complement receptor type 1-related protein y (Crry) expression in iNSCs after CHI mouse serum treatment. Moreover, both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> loss-of-function studies revealed that iNSCs could modulate complement activation via Crry expression.<\/jats:p>","DOI":"10.1038\/srep45989","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T14:13:53Z","timestamp":1491488033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systemic Administration of Induced Neural Stem Cells Regulates Complement Activation in Mouse Closed Head Injury Models"],"prefix":"10.1038","volume":"7","author":[{"given":"Mou","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"BFsrep45989_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","volume":"32","author":"VM Holers","year":"2014","unstructured":"Holers, V. M. Complement and its receptors: new insights into human disease. Annu. Rev. Immunol. 32, 433\u2013459 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"BFsrep45989_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/imm.12233","volume":"142","author":"S Amor","year":"2014","unstructured":"Amor, S. et al. Inflammation in neurodegenerative diseases--an update. Immunology 142, 151\u2013166 (2014).","journal-title":"Immunology"},{"key":"BFsrep45989_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka, M. T., Kummer, M. P. & Latz, E. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 14, 463\u2013477 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFsrep45989_CR4","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin, D. & Lambris, J. D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J. Immunol. 190, 3831\u20133838 (2013).","journal-title":"J. Immunol."},{"key":"BFsrep45989_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1742-2094-9-137","volume":"9","author":"FH Brennan","year":"2012","unstructured":"Brennan, F. H. et al. Complement activation in the injured central nervous system: another dual-edged sword? J. Neuroinflamm. 9, 137 (2012).","journal-title":"J. Neuroinflamm."},{"key":"BFsrep45989_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan, A. H., Barres, B. A. & Stevens, B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35, 369\u2013389 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFsrep45989_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2016.06.013","volume":"74","author":"M Govoni","year":"2016","unstructured":"Govoni, M. et al. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J. Autoimmun. 74, 41\u201372 (2016).","journal-title":"J. Autoimmun."},{"key":"BFsrep45989_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.molimm.2014.06.039","volume":"61","author":"A Jacob","year":"2014","unstructured":"Jacob, A. & Alexander, J. J. Complement and blood-brain barrier integrity. Mol. Immunol. 61, 149\u2013152 (2014).","journal-title":"Mol. Immunol."},{"key":"BFsrep45989_CR9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1089\/08977150152725605","volume":"18","author":"BM Bellander","year":"2001","unstructured":"Bellander, B. M. et al. Complement activation in the human brain after traumatic head injury. J Neurotraum. 18, 1295\u20131311 (2001).","journal-title":"J Neurotraum"},{"key":"BFsrep45989_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fncel.2014.00380","volume":"8","author":"F Orsini","year":"2014","unstructured":"Orsini, F. et al. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front. Cell. Neurosci. 8, 380 (2014).","journal-title":"Front. Cell. Neurosci"},{"key":"BFsrep45989_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-2094-3-22","volume":"3","author":"C Canova","year":"2006","unstructured":"Canova, C., Neal, J. W. & Gasque, P. Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis. J. Neuroinflamm. 3, 22 (2006).","journal-title":"J. Neuroinflamm."},{"key":"BFsrep45989_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.brainres.2009.04.047","volume":"1298","author":"MC Garrett","year":"2009","unstructured":"Garrett, M. C. et al. Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage. Brain Res. 1298, 171\u2013177 (2009).","journal-title":"Brain Res."},{"key":"BFsrep45989_CR13","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/01.WCB.0000084250.20114.2C","volume":"23","author":"M Rancan","year":"2003","unstructured":"Rancan, M. et al. Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice. J. Cereb. Blood Flow Metab. 23, 1070\u20131074 (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFsrep45989_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.expneurol.2006.01.033","volume":"199","author":"I Leinhase","year":"2006","unstructured":"Leinhase, I. et al. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. Exp. Neurol. 199, 454\u2013464 (2006).","journal-title":"Exp. Neurol."},{"key":"BFsrep45989_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2016.04.008","volume":"281","author":"DL Haus","year":"2016","unstructured":"Haus, D. L. et al. Transplantation of human neural stem cells restores cognition in an immunodeficient rodent model of traumatic brain injury. Exp. Neurol. 281, 1\u201316 (2016).","journal-title":"Exp. Neurol."},{"key":"BFsrep45989_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/nn.3163","volume":"15","author":"Z Kokaia","year":"2012","unstructured":"Kokaia, Z. et al. Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat. Neurosci. 15, 1078\u20131087 (2012).","journal-title":"Nat. Neurosci."},{"key":"BFsrep45989_CR17","doi-asserted-by":"publisher","first-page":"e0137211","DOI":"10.1371\/journal.pone.0137211","volume":"10","author":"H Yao","year":"2015","unstructured":"Yao, H. et al. Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats. PloS One 10, e0137211 (2015).","journal-title":"PloS One"},{"key":"BFsrep45989_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbi.2016.09.020","volume":"59","author":"M Gao","year":"2017","unstructured":"Gao, M. et al. Induced neural stem cells modulate microglia activation states via CXCL12\/CXCR4 signaling. Brain Behav. Immun. 59, 288\u2013299 (2017).","journal-title":"Brain Behav. Immun."},{"key":"BFsrep45989_CR19","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1523\/JNEUROSCI.3617-10.2011","volume":"31","author":"M Moriyama","year":"2011","unstructured":"Moriyama, M. et al. Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. J. Neurosci. 31, 3981\u20133989 (2011).","journal-title":"J. Neurosci."},{"key":"BFsrep45989_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcyt.2013.10.011","volume":"16","author":"H Kim","year":"2014","unstructured":"Kim, H. et al. Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation. Cytotherapy 16, 357\u2013368 (2014).","journal-title":"Cytotherapy"},{"key":"BFsrep45989_CR21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3727\/096368912X657620","volume":"22","author":"NL Payne","year":"2013","unstructured":"Payne, N. L. et al. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant. 22, 1409\u20131425 (2013).","journal-title":"Cell Transplant."},{"key":"BFsrep45989_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/brain\/awm306","volume":"131","author":"ST Lee","year":"2008","unstructured":"Lee, S. T. et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131, 616\u2013629 (2008).","journal-title":"Brain"},{"key":"BFsrep45989_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/nprot.2009.148","volume":"4","author":"MA Flierl","year":"2009","unstructured":"Flierl, M. A. et al. Mouse closed head injury model induced by a weight-drop device. Nat. Protoc. 4, 1328\u20131337 (2009).","journal-title":"Nat. Protoc."},{"key":"BFsrep45989_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/path.4669","volume":"238","author":"S Zeng","year":"2016","unstructured":"Zeng, S. et al. Molecular response of chorioretinal endothelial cells to complement injury: implications for macular degeneration. J. Pathol. 238, 446\u2013456 (2016).","journal-title":"J. Pathol."},{"key":"BFsrep45989_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-3083.2009.02253.x","volume":"69","author":"ED Pedersen","year":"2009","unstructured":"Pedersen, E. D. et al. In situ deposition of complement in human acute brain ischaemia. Scand. J. Immunol. 69, 555\u2013562 (2009).","journal-title":"Scand. J. Immunol"},{"key":"BFsrep45989_CR26","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1182\/blood.V99.10.3707","volume":"99","author":"T Miwa","year":"2002","unstructured":"Miwa, T. et al. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99, 3707\u20133716 (2002).","journal-title":"Blood"},{"key":"BFsrep45989_CR27","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1182\/blood.V100.9.3304","volume":"100","author":"TA Caragine","year":"2002","unstructured":"Caragine, T. A. et al. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity. Blood 100, 3304\u20133310 (2002).","journal-title":"Blood"},{"key":"BFsrep45989_CR28","doi-asserted-by":"publisher","first-page":"29955","DOI":"10.1038\/srep29955","volume":"6","author":"M Gao","year":"2016","unstructured":"Gao, M. et al. Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain. Sci. Rep. 6, 29955 (2016).","journal-title":"Sci. Rep"},{"key":"BFsrep45989_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI24521","volume":"116","author":"JM Thurman","year":"2006","unstructured":"Thurman, J. M. et al. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia\/reperfusion. J. Clin. Invest. 116, 357\u2013368 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFsrep45989_CR30","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ajpath.2014.06.001","volume":"184","author":"V Lyzogubov","year":"2014","unstructured":"Lyzogubov, V. et al. Complement regulatory protein CD46 protects against choroidal neovascularization in mice. Am. J. Pathol. 184, 2537\u20132548 (2014).","journal-title":"Am. J. Pathol."},{"key":"BFsrep45989_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1742-2094-10-119","volume":"10","author":"JD Lee","year":"2013","unstructured":"Lee, J. D. et al. Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Neuroinflamm. 10, 119 (2013).","journal-title":"J. Neuroinflamm."},{"key":"BFsrep45989_CR32","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.4049\/jimmunol.178.3.1783","volume":"178","author":"NS Bora","year":"2007","unstructured":"Bora, N. S. et al. CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J. Immunol. 178, 1783\u20131790 (2007).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep45989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep45989","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/srep45989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/srep45989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T23:33:23Z","timestamp":1671838403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep45989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,31]]}},"alternative-id":["BFsrep45989"],"URL":"https:\/\/doi.org\/10.1038\/srep45989","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]},"assertion":[{"value":"16 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45989"}}